Bridgefront Capital’s Exact Sciences EXAS Stock Holding History

Bridgefront Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,092	Closed	-$619K	–	604
2025 Q4	$619K	Sell	6,092 -5,902	-49%	-$474K	0.16%	222
2025 Q3	$656K	Buy	+11,994	New	+$599K	0.19%	175
2023 Q4	–	Sell	-4,049	Closed	-$276K	–	428
2023 Q3	$276K	Buy	+4,049	New	+$344K	0.19%	223
2021 Q1	–	Sell	-6,261	Closed	-$830K	–	750
2020 Q4	$830K	Buy	+6,261	New	+$757K	0.28%	89

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bridgefront Capital's EXAS Position: Q1 2026 in Review

Bridgefront Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,092 shares — an estimated $619K sold.

Bridgefront Capital first reported a position in EXAS in Q4 2020 and held it in 4 quarters. The position peaked at $830K in Q4 2020. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Bridgefront Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Bridgefront Capital sold 6,092 Exact Sciences shares in Q1 2026, an estimated $619K.
Bridgefront Capital first reported a position in Exact Sciences in Q4 2020 and held it in 4 quarters.
Bridgefront Capital's Exact Sciences position peaked at $830K in Q4 2020.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.